Home › Funds › MIC Capital Management UK LLP › LYEL

MIC Capital Management UK LLP position in LYEL

LYELL IMMUNOPHARMA INC · Health Care

MIC Capital Management UK LLP reported holding 87,028 shares of LYEL (LYELL IMMUNOPHARMA INC) in its Q3 2026 13F filing — a position valued at US$852K, representing 0.18% of its reported portfolio and ranking #12 among its reported holdings. MIC Capital Management UK LLP has disclosed LYEL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)87.03K sh
Reported value held$852.00K
Portfolio Weight0.18%
First reportedQ3 2023
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How MIC Capital Management UK LLP's LYEL position evolved

MIC Capital Management UK LLP first disclosed a stake in LYEL in Q3 2023 at 1,740,569 shares (US$2.6M). The position peaked in Q1 2024 at 1,740,569 shares, worth US$3.9M. Across 13 filings, MIC Capital Management UK LLP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 87,028 shares valued at US$852K. Notable position changes include a 95% trim in Q2 2025 (shares rose 84% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.74M $2.56M New
Q4 2023 1.74M $3.38M Hold
Q1 2024 1.74M $3.88M Hold
Q2 2024 1.74M $2.52M Hold
Q3 2024 1.74M $2.40M Hold
Q4 2024 1.74M $1.11M Hold
Q1 2025 1.74M $936.43K Hold
Q2 2025 87.03K $769.33K Reduce
Q3 2025 87.03K $1.41M Hold
Q4 2025 87.03K $2.68M Hold
Q1 2026 87.03K $1.75M Hold
Q2 2026 87.03K $1.22M Hold
Q3 2026 87.03K $852.00K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LYEL and 13F data

LYEL (LYELL IMMUNOPHARMA INC) is a Health Care company. 27 other funds we track also report a position in LYEL — the largest reported positions include ARCH Venture Management, LLC (US$45.5M), GSK plc (US$14.8M), Almitas Capital LLC (US$8.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LYEL

All LYEL fund holders →

FAQ

How long has MIC Capital Management UK LLP held LYEL?

MIC Capital Management UK LLP has disclosed LYEL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is MIC Capital Management UK LLP's current position in LYEL?

As of Q3 2026, MIC Capital Management UK LLP holds 87.03K shares of LYEL (LYELL IMMUNOPHARMA INC), valued at $852.00K, representing 0.18% of its reported portfolio and ranking #12.

Has MIC Capital Management UK LLP been buying or selling LYEL?

In the latest 13F filing (Q3 2026), MIC Capital Management UK LLP held unchanged its position in LYEL. The position peaked in Q1 2024 at 1.74M shares.

Which other funds hold LYEL?

Other major institutional holders of LYEL include ARCH Venture Management, LLC, GSK plc, Almitas Capital LLC, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.